Prostate Cancer Coverage from Every Angle

Recent News

Dual Pathway Inhibition Under Study in Metastatic Castration-Resistant Prostate Cancer
Do Common Prostate Cancer Treatments Cause Cognitive Decline?
EAU21: Active Surveillance Versus Treatment for Older Men With Low-Risk Prostate Cancer
Comparing Imaging Modalities After Prostatectomy to Guide Radiotherapy Decision-Making
Phase II Study of Bipolar Androgen Therapy and Nivolumab in Prostate Cancer
Early Results With PSMA-Targeting T-Cell Engager in Metastatic Prostate Cancer
ASCO 2021: Prostate Cancer Treatment Disparities During First Wave of COVID-19 Pandemic
ASCO 2021: Bone-Protecting Agents With Enzalutamide Treatment for Metastatic Prostate Cancer
FDA Brief: Radioligand Therapy Receives Breakthrough Therapy Designation in Prostate Cancer
Long-Terms Results With Apalutamide Plus ADT in Metastatic Prostate Cancer
ASCO 2021: Early-Phase Study of Alpha Emitter in Castration-Resistant Prostate Cancer
ASCO 2021: ADT Plus Novel Targeted Therapy in Metastatic Prostate Cancer
Risk of Cardiovascular Events Following Hormone Therapy for Prostate Cancer
ASCO 2021: PEACE-1 Trial of Abiraterone-Based Combination Therapy in Metastatic Prostate Cancer
ASCO 2021: Radiolabeled Antibody Plus Standard of Care for PSMA-Positive Prostate Cancer
Sleep Quality and Depression in Men With Prostate Cancer
First PSMA PET Imaging Agent for Prostate Cancer Approved by FDA
Role of ERβ and EGFR in Prostate Cancer: Therapeutic Implications
ASCO 2021: Does PSA Screening Intensity Impact Outcomes in Younger Black Men With Prostate Cancer?
Kidney Health With Androgen-Deprivation Therapy for Prostate Cancer
Can Waist Circumference and Body Shape Index Influence the Risk of Prostate Cancer?
Molecular and Genomic Differences in Prostate Cancer: Impact on Racial Disparities in Treatment
Is Adding Palbociclib to Androgen-Deprivation Therapy of Benefit in Prostate Cancer?
Localized Intermediate-Risk Prostate Cancer: MRI-Guided Focused Ultrasound Ablation
AACR 2021: Exploratory Analysis of Molecular Signatures From TITAN Trial in Prostate Cancer
AACR 2021: Is the B7-H3 Protein an Actionable Target in Prostate Cancer?
AACR 2021: Prostate Cancer Risk, Obesity, and Diabetes
AACR 2021: Role of a Healthy Lifestyle in Offsetting Genetic Risks for Prostate Cancer
Cardiovascular Risk Factors and Prostate Cancer in U.S. Veterans
AACR 2021: Nivolumab Plus Ipilimumab in Biomarker-Selected Patients With Metastatic Prostate Cancer
Are Antiepileptic Drugs Linked to Reduced Risk of Prostate Cancer?
Urologists’ Attitudes About Active Surveillance for Low-Risk Prostate Cancer: Survey Findings
Phase III Trial Update on Ipatasertib Plus Abiraterone in Metastatic Prostate Cancer
Can White Button Mushroom Extract Slow the Growth of Prostate Cancer?
Erectile Dysfunction and Sexual Satisfaction After Robot-Assisted Radical Prostatectomy
Nivolumab Plus Docetaxel for Metastatic Castration-Resistant Prostate Cancer
Active Surveillance for Low-Risk Prostate Cancer: Practice Variation by Geographic Location
KEYNOTE-365 Update on Pembrolizumab Plus Chemotherapy for Metastatic Prostate Cancer
Novel Protein Inhibitor CCS1477 Under Study in Treatment-Resistant Prostate Cancer
Are Genetic Factors Potentially Driving Prostate Cancer in Black Individuals?
GU Symposium 2021: Adding Pembrolizumab to Radium-223 for Metastatic Castration-Resistant Prostate Cancer
Taking on Prostate Cancer and Myeloma: A Man Named Steele
GU Symposium 2021: Novel Tool for Predicting Metastasis After Radiotherapy for Prostate Cancer
GU Symposium 2021: Dose-Intensified Approach to Salvage Radiotherapy in Biochemically Recurrent Prostate Cancer
$3.8 Million Donation to Mount Sinai to Support Accessibility to Prostate Cancer Screening for Black Men
GU Symposium 2021: Final TITAN Trial Results in Metastatic Prostate Cancer
Delays in Radical Prostatectomy: Oncologic Outcomes in High-Risk Prostate Cancer
GU Symposium 2021: Final ACIS Results on Apalutamide-Based Therapy for Metastatic Prostate Cancer
GU Symposium 2021: Results From the Biomarker Cohort of the Phase III SPARTAN Trial
GU Symposium 2021: Does Less PSA Screening Mean More Metastatic Prostate Cancer?
Is Extended Pelvic Lymph Node Dissection Associated With Perioperative Complications?

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.